Hot topics

Hot topics

​Join in with the latest conversations taking place across pharmacy.
May 04, 2022

Statement on Aquiette Proposal by Dr Julian Spinks

My name is Dr Julian Spinks and I am a general practitioner with a specialist interest in the management of incontinence. The proposal to make low-dose oxybutynin (Aquiette) available through pharmacies needs to be viewed against a background of the large number of women who suffer from urinary incontinence caused by overactive bladder. Despite the increasing visibility of incontinence products in adverts, incontinence continues to be a condition which is associated with significant embarrassment and stigma. This often leads to long delays before women seek help from healthcare professionals. These women miss out on early opportunities to treat the underlying cause of their incontinence, such as overactive bladder. Widening the availability of treatment with low-dose oxybutynin through pharmacies offers women with the early stages of overactive bladder an additional way to receive the help they need if they do not wish to consult their GP or a continence service. Oxybutynin is already widely in use as a prescription-only treatment for overactive bladder and, together with other anticholinergic bladder drugs, remains recommended by NICE as a first-line prescribed pharmacological treatment for overactive bladder following bladder training (Bladder training is a way of teaching the bladder to hold more urine and helps to reduce the number of times a person needs to pass urine and to reduce incontinence) Long-term use Oxybutynin is not suitable for some women, particularly older women who are at a greater risk of physical or mental decline and NICE recommends it is not used in this group. The current proposal is for short-term (12 weeks maximum), low-dose, oxybutynin in 18 to 65 year-olds. This would only be offered after a pharmacist has assessed to ensure it is appropriate to use in the individual. The dose and duration proposed are highly unlikely to present the same concerns than long term use of higher-dose anticholinergic medications on prescription. The oxybutynin is being offered together with bladder training. This offers an opportunity for the woman to reduce the progression of her overactive bladder and should diminish the need for ongoing pharmacological treatment at the end of the course. An additional proposed protection is that those women who continue to have problems will be advised to seek advice from their doctor or from a continence service. Given the large numbers of women who do not seek help but continue to suffer from urinary incontinence due to overactive bladder, I view the availability of low-dose oxybutynin through pharmacies to be an extremely positive development and an important way to improve women’s health.
Apr 15, 2022

A PUBLIC VIEWPOINT

Why would a pharmacist refuse to sell me, a pensioner, a common medical product I have used throughout my life to treat an occasional condition to good effect? I ask because that is what happened to me this week at my local chemists. The condition was an eye infection - a stye - and the product I sought to buy was Gold Eye Ointment, which I have always found to be easily available. My experience began when, with red, inflamed eye, I was asked by the counter assistant why I wanted the product. I then stood there - feeling somewhat vilified - while the assistant held a lengthy discussion with the pharmacist, to be told he would hold a consultation with me. If I had wanted a consultation I would have seen a GP. The pharmacist then became involved in a consultation with a mother and child, on the shop floor and I decided to leave. He spoke to me as I was leaving and I asked if he would allow me to buy the product - he said no. I purchased the product a short while later from a chemist in the same group a few miles away. The assistant merely asked two questions relating to contact lenses and diabetes. Having read the many articles on this site and elsewhere relating to big developments with pharmacists regarding consultations and fast-track training to become GPs - and the great enthusiasm and, in some cases zeal, created - I understand the drive to offer a better public service. But where are the checks and balances? In my case, and I suspect many others, I was denied the simple opportunity to treat a condition I knew with a product I've known and used since childhood without ill effect. How is this improving anything?
Mar 24, 2022

Did you or your pharmacy make use of any of the provisions under the Coronavirus Act?

The Coronavirus Act formed one of the pillars of the government’s plan to combat the COVID-19 pandemic by envisaging changes in legislation which gave “public bodies across the UK the tools and powers they need to carry out an effective response to [the] emergency” the pandemic presented. Do you think the Coronavirus Act helped pharmacy teams? Do you think it will have a lasting impact on pharmacy?
Mar 23, 2022

Crime in pharmacies: Have you/your team been the victim of crime while at work? Did this involve violence and/or harassment?

The latest revelation from C+D's investigation into crime in pharmacies - #NoExcuseForAbuse - found that police forces in England, Wales and Northern Ireland received at least 1,240 reports of violent crime committed in pharmacies in 2021. https://www.chemistanddruggist.co.uk/CD135991/Pharmacies-hit-by-violent-crime-as-police-record-over-1k-incidents-in-2021 Are you surprised by these findings? What is your experience of crime and or harassment/violence at work? Share your thoughts and stories below, or email Emily.Stearn@informa.com if you wish to remain anonymous
Feb 26, 2022

Will Patients Pay for LFTs?

Do you think people will pay for lateral flow tests? I can't see it happening unless there is an immediate and coerced need to do so. I'm wondering if it is going to have a direct impact on the overall health of the community? Or maybe the variants will become milder to the point where there is no reasonable benefit to isolation? I'd never pay for an LFT. Ever. 
Jan 07, 2022

What is your favourite thing about working in community pharmacy?

There has been a lot of discussion around community pharmacy employers struggling to recruit and retain pharmacists and pharmacy staff, with the prospect of "better working conditions" and career opportunities in primary care prompting many to leave the sector. https://www.chemistanddruggist.co.uk/CD007051/Recognition-of-pharmacist-shortage-welcome-as-sector-loses-out-to-PCNs Also see C+D's Big Debate on the topic: https://community.chemistanddruggist.co.uk/rooms/the-big-debate/conversations/41408 But Shenu Barclay recently celebrated 45 years in community pharmacy and shows no signs of stopping a career that she loves, but didn't choose. https://www.chemistanddruggist.co.uk/CD135820/Saving-lives-facing-gunpoint-serving-celebrities-one-pharmacists-45-years-in-community-pharmacy What do you love about working in community pharmacy? Share your favourite experiences and career highlights below
Jan 06, 2022

COVID tests and the PSNC

The most important questions about the current debacle are - Who in the PSNC thought it would be acceptable (much less a good idea) to say yes to the stupidity of the 16 digit code? what did they think this would take in terms of resources? did the contractors agree to put in extra to cope, paid for by the payment we recieve? for too long they have said yes to ANYTHING which brings in a few mor pennies irrespective of how much work is involved... maybe they should be the ones doing it.
Dec 06, 2021

Would you support the introduction of a pharmacist apprenticeship scheme?

The discussions around introducing a pharmacist apprenticeship resumed this summer after its unintentional sabbatical due to COVID-19. Meanwhile, the proposals for a doctor degree-level apprenticeship have seemingly been welcomed by the majority, says Sean Quay in his latest blog. Have these factors prompted you to reconsider the pharmacist apprenticeship proposals too?  Share your thoughts below
Dec 04, 2021

What do you make of the Boots UK sale rumours?

With the news that Boots' parent company is rumoured to be "exploring" the sale of its pharmacies in the UK - according to Sky News - what impact could this have on the UK pharmacy market? Read C+D's story and share your thoughts: https://www.chemistanddruggist.co.uk/CD135763/Boots-parent-company-rumoured-to-be-exploring-selling-off-UK-pharmacies
Nov 24, 2021

What are you thoughts on implementing hub-and-spoke?

The General Pharmaceutical Council (GPhC) CEO Duncan Rudkin has said that the regulator will consider whether “additional guidance is required” if the legislation is changed to roll out the hub-and-spoke model across all pharmacies. Gareth Jones, head of corporate affairs at the NPA, stressed that it was up to individual businesses to implement hub and spoke in the future and assess whether it would benefit them. However, Mr Jones argued that there is not “a huge business incentive for independent pharmacies” to introduce the model. “I don’t see [hub and spoke] revolutionising pharmacy practice within multiples either”, Mr Jones continued.
Nov 17, 2021

CCA: More pharmacy closures 'unavoidable' due to pharmacist shortage

This is a complete nonsense. There are well over 55K registered pharmacists on the register, and with no more than 12K working in the community sector.I would only believe this article when i see community pharmacies closing or changing hands for nil goodwill. The temporary closures and reduced hours opening is to portray a false scenario of work overload and shortage of workforce to retain as much profit as possible. Such scenarios are also engineered to hold the NHS England and/or the government  to ransom, and and extract and retain as much of the funding as possible. The contractors also use NHS funded Platform to provide private services at extortionate profit!!
Nov 15, 2021

Codeine death case ?

I am disappointed that a full tail is not reflected on regarding the death of the nurse who died due to a combination of medication. Although I don't know the full storey there are numerous points which needs to be addressed ... Why did the GP stop prescribing the medication? Was she referred to a specialist substance misuse clinic what was the status of her mental health addressed? I do NOT believe that the major contributory factor was that of codeine being bought OTC  I agree that the sale of codeine linctus needs some more checks and balances but it is unreasonable to state that this could be the major cause of her death  May her soul be blessed God rest her soul
Nov 09, 2021

Does your pharmacy offer the Pharmacy Collect service?

More than £20m was paid to community pharmacy owners in England who submitted their claims for COVID-19 lateral flow test kit transactions in the first five months of the Pharmacy Collect service, C+D can reveal. Full story here: https://www.chemistanddruggist.co.uk/CD135702/Contractors-earned-over-20m-in-service-fees-in-first-5-months-of-Pharmacy-Collect Meanwhile, C+D revealed earlier this year that the sector cashed in just over £6m for Community Pharmacist Consultation Service claims. Do you think the Pharmacy Collect service is working well? Should it be commissioned indefinitely?
Nov 05, 2021

Have your working arrangements changed since the introduction of IR35?

The PDA has advised locum pharmacists they “are under no direct obligation” to help contractors gather data for an HMRC investigation into off-payroll working rules - also known as IR35 - although they “may choose to do so to help ensure HMRC reaches a final decision".  PDA: Locums may assist contractors in HMRC IR35 probe but ‘no obligation’ to do so :: C+D (chemistanddruggist.co.uk)

About this room

A place for you to join hot topic conversations as posted by C+D; or start your own! 

It's easy to start a conversation - simply following the steps in our FAQs here